A late-term maneuver by President Donald Trump to use lower drug prices paid overseas to limit some of Medicare’s own costs suffered a legal setback last Wednesday that appears likely to keep the policy from taking effect before the president …
As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc., could charge up to $10,000 for the treatment. Then a small but increasingly …
The Trump administration on Wednesday said it will require drug makers to disclose the list price of prescription drugs in direct-to-consumer television advertisements, part of the government’s efforts to lower costs for U.S. consumers. The list price would be included …
The U.S. government, in an effort to increase pressure on drugmakers to lower costs for U.S. consumers, said on Monday it will propose requiring companies to include the price of their prescription medicines in television ads. Health and Human Services …
U.S. prices for the world’s 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters. The finding underscores a transatlantic gulf between the price of treatments for a range of …
